Related Experiment Video
Updated: Dec 16, 2025

09:46
Analyzing Murine Schwann Cell Development Along Growing Axons
Published on: November 21, 2012
12.0K
Pathomechanisms in schwannoma development and progression
Dario-Lucas Helbing1,2, Alexander Schulz1,3, Helen Morrison4
1Leibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany.
Oncogene
|July 4, 2020
Summary
Schwannomas involve multiple cell types beyond Schwann cells, forming a complex tumor microenvironment. Understanding these interactions is key to addressing peripheral nervous system tumor development.
Area of Science:
- Oncology
- Neuroscience
- Cell Biology
Background:
- Schwannomas are peripheral nervous system tumors originating from Schwann cells.
- These tumors comprise a complex microenvironment including axons, immune cells, fibroblasts, and extracellular matrix.
- While Nf2 gene mutations drive tumorigenesis, other cell types contribute to schwannoma pathology.
Purpose of the Study:
- To review the intra- and intercellular mechanisms involved in schwannoma formation.
- To highlight the roles of diverse cell types within the tumor microenvironment.
- To consolidate current understanding of schwannoma development beyond the primary tumorigenic cells.
Main Methods:
- Literature review of intra- and intercellular mechanisms in schwannoma development.
- Analysis of the contribution of various cell types to the tumor microenvironment.
- Synthesis of research on the role of the Nf2 tumor suppressor gene.
Main Results:
- Schwannoma development is influenced by a complex interplay of multiple cell types.
- The tumor microenvironment, including immune cells and fibroblasts, plays a significant role.
- Non-Schwann cell components are increasingly recognized as critical factors in tumor progression.
Conclusions:
- Schwannoma formation is a multifaceted process involving a complex tumor microenvironment.
- Targeting interactions within this microenvironment may offer new therapeutic strategies.
- Further research into the roles of non-Schwann cells is crucial for understanding and treating these tumors.
Related Concept Videos
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Neurogenesis and Regeneration of Nervous Tissue
1.4K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.4K
Nervous Tissue: Myelin
4.9K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
4.9K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K

